TheStreet’s Jim Cramer discussed the bear market in biotechs while answering viewer questions from social media on Friday. A viewer asked about Regeneron (REGN), and Cramer responded ‘I’m not going to say don’t buy Regeneron, not down here. I like it.’ Cramer also talked about how Celgene (CELG), Biogen (BIIB) and Amgen (AMGN) have all been slammed. Cramer was asked about Oracle (ORCL) and he said the stock is okay, but he likes Salesforce.com (CRM), which is winning business. A viewer wanted to know about Nestle (NSRGY), and Cramer said if the dollar has peaked, it’s not a good long term play. He does like Coca-Cola (KO), which he believes will move much higher. Cramer is portfolio manager of Action Alerts PLUS. Send your questions to Cramer on Facebook or Twitter, use hashtag CramerQ.
More from Video
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.
There is a lot of Apple news to chew on Wednesday.